RSV

ATLANTA — The Centers for Disease Control and Prevention has issued an “urgent” alert to health care providers to notify them of the current low rate of vaccinations against the flu, COVID-19 and the respiratory syncytial virus, also known as... Read More

WASHINGTON — Senior Biden-Harris administration officials this week urged the makers of shots to prevent respiratory syncytial virus, more popularly known as RSV, to step up the pace of their work ahead of the onset of winter. Monday’s meeting followed... Read More

ATLANTA — The Centers for Disease Control and Prevention is recommending the rationing of doses of an injection to protect young infants from RSV due to shortages of the recently approved product Beyfortus. In a health alert issued Monday, the... Read More

WASHINGTON — The Food and Drug Administration on Wednesday licensed the first-ever vaccine for respiratory syncytial virus, or RSV, a highly contagious virus that is a common cause of lower respiratory tract disease in older adults. The vaccine, Arexvy, was... Read More

WASHINGTON — A panel of advisors to the Food and Drug Administration narrowly voted on Tuesday to endorse an experimental vaccine from Pfizer to protect older adults against the highly contagious lower respiratory tract ailment RSV. The advisors voted 7-4... Read More

New research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals with wheezing babies each fall. The preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV... Read More

As a record number of children are being hospitalized with COVID-19, pediatric hospitals are reporting heightened outbreaks of respiratory syncytial virus which can be life-threatening to infants and young adults. Usually, outbreaks of RSV hit their peak between December and... Read More